Dyanavel XR FDA Approval History
FDA Approved: Yes (First approved October 19, 2015)
Brand name: Dyanavel XR
Generic name: amphetamine
Dosage form: Extended-Release Oral Suspension and Extended-Release Tablets
Company: Tris Pharma, Inc.
Treatment for: ADHD
Dyanavel XR (amphetamine) is an extended-release central nervous system (CNS) stimulant for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
Development Timeline for Dyanavel XR
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.